Massachusetts Financial Services’s BioLife Solutions BLFS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$30.5M Sell
1,079,270
-117,987
-10% -$2.76M 0.01% 587
2026
Q1
$22.8M Buy
1,197,257
+193,093
+19% +$4.27M 0.01% 614
2025
Q4
$24.3M Sell
1,004,164
-93,188
-8% -$2.44M 0.01% 613
2025
Q3
$28M Sell
1,097,352
-4,739
-0.4% -$112K 0.01% 580
2025
Q2
$23.7M Buy
1,102,091
+337,420
+44% +$7.61M 0.01% 589
2025
Q1
$17.5M Buy
764,671
+1,768
+0.2% +$46.6K 0.01% 609
2024
Q4
$19.8M Buy
+762,903
New +$19M 0.01% 602

Other funds holding BLFS

Massachusetts Financial Services's BLFS Position: Q2 2026 in Review

Massachusetts Financial Services reduced its BioLife Solutions (BLFS) stake by 9.9% in Q2 2026, selling an estimated $2.76M and leaving 1,079,270 shares worth $30.5M. The position accounts for 0.01% of the portfolio, ranked #587.

Massachusetts Financial Services first reported a position in BLFS in Q4 2024 and has held it in 7 quarters since. 216 funds tracked by Wall St. Rank hold BLFS as of Q2 2026.

  • Massachusetts Financial Services held 1,079,270 shares of BioLife Solutions worth $30.5M as of Q2 2026.
  • Massachusetts Financial Services sold 117,987 BioLife Solutions shares in Q2 2026, an estimated $2.76M.
  • BioLife Solutions made up 0.01% of Massachusetts Financial Services's portfolio in Q2 2026, its #587 holding.
  • Massachusetts Financial Services first reported a position in BioLife Solutions in Q4 2024 and has held it in 7 quarters since.
  • 216 funds tracked by Wall St. Rank held BioLife Solutions as of Q2 2026.

Based on Massachusetts Financial Services's 13F filing for Q2 2026, filed 3 Aug 2026.